Ownership history in UBS Group AG · 3 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CERO THERAPEUTICS HLDGS INC (CERO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 6 | -2,619 | -99.8% | 0.00% | $30 | $5.09 |
| 2025 Q2 | REDUCED | 2,625 | -40,062 | -93.9% | 0.00% | $25K | $9.63 |
| 2025 Q1 | INITIATED | 42,687 | — | — | 0.00% | $31K | $14.60 |
As of 2025 Q3 — sorted by position size